← Leaderboards
Jianyi Zhang
University Of Alabama At Birmingham
$29,820,074
Attributed
$48,471,617
Total exposure
19
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,535,048 · 20
By mechanism
R01$28,677,172 · 9
U01$15,451,226 · 2
P01$11,960,653 · 5
T32$752,788 · 1
R21$660,609 · 1
R13$32,600 · 2
Top collaborators
- Nenad Bursac7 shared
- Daniel J. Garry7 shared
- Timothy J Kamp7 shared
- Dan S Kaufman7 shared
- Michael Kyba7 shared
- Vahid Serpooshan7 shared
- Jack M Rogers5 shared
- Prasanna Krishnamurthy4 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Vahid Serpooshan$4,036,108
Others in their field
Top investigators on “Myocardial Infarction”
- Judith S Hochman · New York University School Of Medicine$121,330,744
- Paul M. Ridker · Brigham And Women'S Hospital$57,742,470
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$57,397,502
- Pamela Susan Douglas · Duke University$51,876,470
- Julie E Buring · Brigham And Women'S Hospital$46,647,558
- Walter N Kernan · Yale University$42,197,025
Research focus
Myocardial InfarctionHeartMyocardialCardiacCellsFamily SuidaeMyocardiumCardiac MyocytesHeart FailureLeft Ventricular RemodelingBioenergeticsInfarctionCongestive Heart FailureVentricularRepairedEngraftmentStem CellsNatural RegenerationReportingMuscle CellsTransplantationBlood VesselsFunctional DisorderMagnetic Resonance Imaging
Grant awards (98)
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury$2,067,432
P01 · FY2025 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$656,462
R01 · FY2025 · HL · contact PI
Improving Cardiac Microenvironment as a Novel Strategy against Diabetic Ischemic Heart Failure$637,732
R01 · FY2025 · HL
Project 1 - Endogenous and Exogenous Mechanisms that Promote Myocardial Remuscularization$364,179
P01 · FY2025 · HL · contact PI
Core A: Administrative Core$205,864
P01 · FY2025 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$47,404
R01 · FY2025 · HL · contact PI
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury$2,280,760
P01 · FY2024 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$659,768
R01 · FY2024 · HL · contact PI
Project 1 - Endogenous and Exogenous Mechanisms that Promote Myocardial Remuscularization$542,257
P01 · FY2024 · HL · contact PI
Core A: Administrative Core$215,610
P01 · FY2024 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$69,145
R01 · FY2024 · HL · contact PI
Advances in Cardiovascular Science: From Discovery to Translation$20,000
R13 · FY2024 · HL · contact PI
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury$2,327,307
P01 · FY2023 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$673,109
R01 · FY2023 · HL · contact PI
Project 1 - Endogenous and Exogenous Mechanisms that Promote Myocardial Remuscularization$553,325
P01 · FY2023 · HL · contact PI
Core A: Administrative Core$220,009
P01 · FY2023 · HL · contact PI
Supplement of HL131017: Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$21,741
R01 · FY2023 · HL · contact PI
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury$2,387,932
P01 · FY2022 · HL · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,164,534
U01 · FY2022 · HL · contact PI
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes$688,624
R01 · FY2022 · HL · contact PI
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals$624,149
R01 · FY2022 · HL · contact PI
Core A: Administrative Core$397,990
P01 · FY2022 · HL · contact PI
Project 1 - Endogenous and Exogenous Mechanisms that Promote Myocardial Remuscularization$397,988
P01 · FY2022 · HL · contact PI
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training Grant$160,991
T32 · FY2022 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,168,782
U01 · FY2021 · HL · contact PI
Mesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial Ischemia$660,745
R01 · FY2021 · HL
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals$624,149
R01 · FY2021 · HL · contact PI
Endogenous and exogenous mechanisms that promote myocardial remuscularization in post infarction LV remodeling$519,750
R01 · FY2021 · HL · contact PI
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training Grant$174,096
T32 · FY2021 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,172,627
U01 · FY2020 · HL · contact PI
Mesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial Ischemia$660,745
R01 · FY2020 · HL
Cell Therapy in Hypertrophied and Remodeled Left Ventricle$628,744
R01 · FY2020 · HL · contact PI
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals$624,149
R01 · FY2020 · HL · contact PI
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training Grant$165,040
T32 · FY2020 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,176,595
U01 · FY2019 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$733,001
R01 · FY2019 · HL · contact PI
Mesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial Ischemia$660,745
R01 · FY2019 · HL
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals$648,399
R01 · FY2019 · HL · contact PI
Cell Therapy in Hypertrophied and Remodeled Left Ventricle$628,744
R01 · FY2019 · HL · contact PI
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training Grant$169,689
T32 · FY2019 · EB · contact PI
Cardiovascular Bioengineering (CVBE) Symposium - 2019$12,600
R13 · FY2019 · HL · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,162,722
U01 · FY2018 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$733,001
R01 · FY2018 · HL · contact PI
Mesenchymal Stem Cell Exosome in Efferocytosis of Apoptotic Cardiomyocytes and Repair after Myocardial Ischemia$660,745
R01 · FY2018 · HL
Cell Therapy in Hypertrophied and Remodeled Left Ventricle$628,744
R01 · FY2018 · HL · contact PI
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training Grant$82,972
T32 · FY2018 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$903,257
U01 · FY2017 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$733,001
R01 · FY2017 · HL · contact PI
Cell Therapy in Hypertrophied and Remodeled Left Ventricle$646,454
R01 · FY2017 · HL · contact PI
Mycardial Repair Using Human iPSC Derived Cardiac Muscle Patch$471,526
R01 · FY2017 · HL · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$949,976
U01 · FY2016 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$756,501
R01 · FY2016 · HL · contact PI
Mycardial Repair Using Human iPSC Derived Cardiac Muscle Patch$471,526
R01 · FY2016 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,104,105
U01 · FY2015 · HL
Bioenergetics in Hypertrophied and Remodeled Left Ventricle$579,957
R01 · FY2015 · HL · contact PI
Myocardial repair using human iPSC derived cardiac muscle patch$479,434
R01 · FY2015 · HL · contact PI
Bioenergetics in Hypertrophied and Remodeled Left Ventricle$64,444
R01 · FY2015 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,098,208
U01 · FY2014 · HL
Bioenergetics in Hypertrophied and Remodeled Left Ventricle$641,132
R01 · FY2014 · HL · contact PI
Myocardial repair using human iPSC derived cardiac muscle patch$486,735
R01 · FY2014 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$421,480
R01 · FY2014 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,066,830
U01 · FY2013 · HL
Bioenergetics in Hypertrophied and Remodeled Left Ventricle$622,813
R01 · FY2013 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$406,506
R01 · FY2013 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2012 · HL
Bioenergetics in Hypertrophied and Remodeled Left Ventricle$667,215
R01 · FY2012 · HL · contact PI
Stem Cells For Myocardial Repair: A Large Bore Magnet Study$474,645
R01 · FY2012 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$421,568
R01 · FY2012 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2011 · HL
Stem Cells For Myocardial Repair: A Large Bore Magnet Study$478,470
R01 · FY2011 · HL · contact PI
Stem Cell Therapy for Myocardial Repair$420,295
R01 · FY2011 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,109,850
U01 · FY2010 · HL
Stem Cells For Myocardial Repair: A Large Bore Magnet Study$480,910
R01 · FY2010 · HL · contact PI
Stem Cell Therapy and Postinfarction LV Remodeling$404,000
R01 · FY2010 · HL · contact PI
Midwestern Progenitor Cell Consortium$1,132,500
U01 · FY2009 · HL
Stem Cells For Myocardial Repair: A Large Bore Magnet Study$477,223
R01 · FY2009 · HL · contact PI
Stem Cell Therapy and Postinfarction LV Remodeling$400,238
R01 · FY2009 · HL · contact PI
Energetics in Hypertrophied and Remodeled Left Ventricle$318,945
R01 · FY2009 · HL · contact PI
Stem Cell Therapy and Postinfarction LV Remodeling$388,582
R01 · FY2008 · HL · contact PI
Energetics in Hypertrophied and Remodeled Left Ventricle$318,945
R01 · FY2008 · HL · contact PI
Stem Cell Therapy and Postinfarction LV Remodeling$384,963
R01 · FY2007 · HL · contact PI
Energetics in Hypertrophied and Remodeled Left Ventricle$318,945
R01 · FY2007 · HL · contact PI
Energetics in Hypertrophied and Remodeled Left Ventricle$328,471
R01 · FY2006 · HL · contact PI
Energetics in Hypertrophied and Remodeled Left Ventricle$336,375
R01 · FY2005 · HL
Stem Cell Therapy and Postinfarction LV Remodeling$371,250
R01 · FY2004 · HL
Stem cell patch therapy in hearts with LV infarction$220,203
R21 · FY2004 · HL
Stem Cell Therapy and Postinfarction LV Remodeling$371,250
R01 · FY2003 · HL
Stem cell patch therapy in hearts with LV infarction$220,203
R21 · FY2003 · HL
MYOCARDIAL ENERGY METABOLISM IN THE DYSFUNCTIONAL LV$135,312
R01 · FY2003 · HL
Stem Cell Therapy and Postinfarction LV Remodeling$371,250
R01 · FY2002 · HL
ENERGETICS IN HYPERTROPHIED AND REMODELED LEFT VENTRICLE$266,673
R01 · FY2002 · HL
Stem cell patch therapy in hearts with LV infarction$220,203
R21 · FY2002 · HL
MYOCARDIAL ENERGY METABOLISM IN THE DYSFUNCTIONAL LV$132,057
R01 · FY2002 · HL
Stem Cell Therapy and Postinfarction LV Remodeling$371,250
R01 · FY2001 · HL
ENERGETICS IN HYPERTROPHIED AND REMODELED LEFT VENTRICLE$259,592
R01 · FY2001 · HL
MYOCARDIAL ENERGY METABOLISM IN THE DYSFUNCTIONAL LV$128,897
R01 · FY2001 · HL
ENERGETICS IN HYPERTROPHIED AND REMODELED LEFT VENTRICLE$252,718
R01 · FY2000 · HL
MYOCARDIAL ENERGY METABOLISM IN THE DYSFUNCTIONAL LV$125,829
R01 · FY2000 · HL